SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xiong-fei Huang, Wei-yu Zhao, Wen-dong Huang, FXR and liver carcinogenesis, Acta Pharmacologica Sinica, 2015, 36, 1, 37

    CrossRef

  2. 2
    Frank G. Schaap, Peter L.M. Jansen, , Steven W.M. OIde Damink, FXR, intestinal FiXeR of hepatocellular carcinoma?, Hepatology, 2015, 61, 1
  3. 3
    Katrin Wlcek, Bruno Stieger, ATP-binding cassette transporters in liver, BioFactors, 2014, 40, 2
  4. 4
    Carol J. Soroka, James L. Boyer, Biosynthesis and trafficking of the bile salt export pump, BSEP: Therapeutic implications of BSEP mutations, Molecular Aspects of Medicine, 2014, 37, 3

    CrossRef

  5. 5
    Anna Baghdasaryan, Peter Chiba, Michael Trauner, Clinical application of transcriptional activators of bile salt transporters, Molecular Aspects of Medicine, 2014, 37, 57

    CrossRef

  6. 6
    Howard R. Mellor, Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations, Liver International, 2014, 34, 6
  7. 7
    Xiulong Song, Alexander Vasilenko, Yuan Chen, Leila Valanejad, Ruchi Verma, Bingfang Yan, Ruitang Deng, Transcriptional dynamics of bile salt export pump during pregnancy: Mechanisms and implications in intrahepatic cholestasis of pregnancy, Hepatology, 2014, 60, 6
  8. 8
    Javier Vaquero, Maria J. Monte, Mercedes Dominguez, Jordi Muntané, Jose J.G. Marin, Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition, Biochemical Pharmacology, 2013, 86, 7, 926

    CrossRef